Full Fed. Circ. Won't Rehear Actelion Spinoff's Patent Term Bid
By Tiffany Hu ( July 29, 2020, 6:32 PM EDT) -- The full Federal Circuit has refused to revisit its decision that a company spun off from Actelion Pharmaceuticals Ltd. when it was purchased by Johnson & Johnson can't get 99 days added to the term of a patent to make up for delays at the U.S. Patent and Trademark Office....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.